SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
Valuation | |
---|---|
Market Cap ($M) | 3,436.29 |
Enterprise Value ($M) | 3,366.54 |
Book Value ($M) | 481.10 |
Book Value / Share | 6.47 |
Price / Book | 7.14 |
NCAV ($M) | 274.29 |
NCAV / Share | 3.69 |
Price / NCAV | 12.53 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.53 |
Return on Assets (ROA) | -0.39 |
Return on Equity (ROE) | -0.45 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 3.70 |
Current Ratio | 3.81 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 380.46 |
Assets | 587.28 |
Liabilities | 106.17 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 191.59 |
Operating Income | -278.13 |
Net Income | -258.13 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -175.60 |
Cash from Investing | 64.55 |
Cash from Financing | 4.76 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Fmr Llc | 1.70 | -88.36 | |
13G/A | Deep Track Capital, LP | 4.65 | -14.84 | |
13G/A | Vanguard Group Inc | 9.62 | 18.59 | |
13G/A | Boxer Capital Management, LLC | 4.60 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
591,924 | 3,716,241 | 15.93 | |
339,402 | 7,378,203 | 4.60 | |
643,691 | 6,271,290 | 10.26 | |
236,172 | 3,124,438 | 7.56 | |
(click for more detail) |
Similar Companies | |
---|---|
STOK – Stoke Therapeutics, Inc. | STTK – Shattuck Labs, Inc. |
SVRA – Savara Inc. | SYRE – Spyre Therapeutics, Inc. |
TARS – Tarsus Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io